Matthew B Maas1, Aneesh B Singhal. 1. Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. mbmaas@northwestern.edu
Abstract
BACKGROUND: Patients with unwitnessed stroke represent >25% of all strokes. Clinical trials enrolling patients with unwitnessed stroke onset have conservatively used last known normal (LKN) as the time of stroke onset. We explored the impact of alternative methods of selecting onset time in unwitnessed strokes on eligibility into an acute stroke therapeutic trial using a representative sample of acute stroke subjects. METHODS: We analyzed data on 641 consecutive patients with suspected stroke presenting to our hospital between January 2007 and July 2008. Time of onset was calculated by 3 methods: (1) LKN, (2) first known abnormal (FKA), and (3) midpoint between LKN and FKA. Subjects with incomplete data or a final diagnosis of nonischemic stroke were excluded. Rates of trial eligibility based on different onset times were compared for several inclusion time windows. RESULTS: Onset time was known in 440 subjects (69%). Of the remaining 201 patients with unwitnessed onset, 114 (57%) were "wake-up" strokes. Among unwitnessed stroke subjects, eligibility increased from 18% using LKN to 57% using FKA at 4.5 hours and 42% to 81% at 9 hours (P < .001), respectively. Overall enrollment eligibility for the full cohort increased from 36% to 48% at 4.5 hours and 61% to 73% at 9 hours (P < .001), respectively. CONCLUSION: Given potential advantages in safety evaluation and the historical inadequate enrollment rates in acute stroke trials, alternative onset time definitions, perhaps in combination with advanced neuroimaging methods (e.g., fluid-attenuated inversion recovery-diffusion-weighted imaging mismatch), should be considered for early-phase trials.
BACKGROUND:Patients with unwitnessed stroke represent >25% of all strokes. Clinical trials enrolling patients with unwitnessed stroke onset have conservatively used last known normal (LKN) as the time of stroke onset. We explored the impact of alternative methods of selecting onset time in unwitnessed strokes on eligibility into an acute stroke therapeutic trial using a representative sample of acute stroke subjects. METHODS: We analyzed data on 641 consecutive patients with suspected stroke presenting to our hospital between January 2007 and July 2008. Time of onset was calculated by 3 methods: (1) LKN, (2) first known abnormal (FKA), and (3) midpoint between LKN and FKA. Subjects with incomplete data or a final diagnosis of nonischemic stroke were excluded. Rates of trial eligibility based on different onset times were compared for several inclusion time windows. RESULTS: Onset time was known in 440 subjects (69%). Of the remaining 201 patients with unwitnessed onset, 114 (57%) were "wake-up" strokes. Among unwitnessed stroke subjects, eligibility increased from 18% using LKN to 57% using FKA at 4.5 hours and 42% to 81% at 9 hours (P < .001), respectively. Overall enrollment eligibility for the full cohort increased from 36% to 48% at 4.5 hours and 61% to 73% at 9 hours (P < .001), respectively. CONCLUSION: Given potential advantages in safety evaluation and the historical inadequate enrollment rates in acute stroke trials, alternative onset time definitions, perhaps in combination with advanced neuroimaging methods (e.g., fluid-attenuated inversion recovery-diffusion-weighted imaging mismatch), should be considered for early-phase trials.
Authors: Götz Thomalla; Philipp Rossbach; Michael Rosenkranz; Susanne Siemonsen; Anna Krützelmann; Jens Fiehler; Christian Gerloff Journal: Ann Neurol Date: 2009-06 Impact factor: 10.422
Authors: Martin Ebinger; Ivana Galinovic; Michal Rozanski; Peter Brunecker; Matthias Endres; Jochen B Fiebach Journal: Stroke Date: 2009-12-24 Impact factor: 7.914
Authors: Robert W Regenhardt; R Gilberto González; Julian He; Michael H Lev; Aneesh B Singhal Journal: Radiology Date: 2021-11-02 Impact factor: 11.105
Authors: Steven D Hajdu; Valerie Pittet; Francesco Puccinelli; Wagih Ben Hassen; Malek Ben Maacha; Raphaël Blanc; Sandra Bracco; Gabriel Broocks; Bruno Bartolini; Tommaso Casseri; Frederic Clarençon; Olivier Naggara; François Eugène; Jean-Christophe Ferré; Alexis Guédon; Emmanuel Houdart; Timo Krings; Pierre Lehmann; Nicola Limbucci; Paolo Machi; Juan Macho; Nicolo Mandruzzato; Sergio Nappini; Marie Teresa Nawka; Patrick Nicholson; João Pedro Marto; Vitor Pereira; Manuel A Correia; Teresa Pinho-E-Melo; João Nuno Ramos; Eytan Raz; Patrícia Ferreira; João Reis; Maksim Shapiro; Eimad Shotar; Noel van Horn; Michel Piotin; Guillaume Saliou Journal: Stroke Date: 2020-07-01 Impact factor: 7.914